News

Takeda is now aiming to increase its global market coverage to approximately 90% by the end of fiscal 2012, one of the key strategic initiatives of the 2010-2012

By providing Pariet as a new treatment option for non-erosive GERD in Japan, Eisai seeks to make further contributions to the treatment of patients with acid-related diseases in

Aprima Medical Software is a developer of electronic health record (EHR), practice management (PM) and revenue cycle management (RCM) solutions for medical practices. CCHIT is an independent, 501(c)3

As per the terms of the expanded agreement, Keith Kendall, executive vice president and chief financial officer of MonoSol Rx, is expected to join Midatech board of directors.

Nektar said that the study is being conducted at University Hospitals Case Medical Center of the Case Comprehensive Cancer Center in Cleveland, Ohio. NKTR-102 is a novel topoisomerase

CaridianBCT is a global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries. The Mirasol system uses the properties of riboflavin

In the trial, all 14 patients were found to have circulating interferon Alpha-2b levels below the bioassay’s lower limit of detection (6.25 pg/mL) at all sampling time points.

With this positive opinion, CHMP has recommended the European Commission to grant the European Marketing Authorisation (MA). The product will be marketed in the EU under the name

MSD and Adcock Ingram intend to co-promote and distribute products from various therapeutic areas including: asthma, dermatology, hypercholesterolemia, hypertension, migraine and osteoporosis as well as a portfolio of